News & Updates

The landmark gift from Helen and Jacob Shaham to Florida International University's Herbert Wertheim College of Medicine represents a transformative investment in the region's life science capabilities, promising to accelerate innovation, attract top talent, and create new opportunities within the burgeoning South Florida biotech ecosystem. This strategic philanthropic commitment underscores a broader trend of private sector and individual support driving public institutions forward, an essential component for sustainable growth in the life sciences.

The University of Miami Miller School of Medicine has published groundbreaking research demonstrating that the integration of GLP-1 receptor agonist therapy markedly enhances post-ablation outcomes for individuals suffering from atrial fibrillation. This pivotal finding underscores a burgeoning connection between metabolic and cardiovascular health, offering new therapeutic avenues and reinforcing South Florida's position at the forefront of medical innovation. For scientists, founders, policymakers, and investors, this study highlights critical opportunities for drug repurposing and integrated care models within the life sciences ecosystem.

A groundbreaking study from Florida Atlantic University highlights a novel mechanism in neurodegeneration, emphasizing South Florida’s growing influence in life science research.

A significant discovery at the Miller School of Medicine could change the landscape of neurotechnology, offering new mobility solutions for patients resistant to traditional treatments.

Miami Dade College's latest AI Innovation Hub at Kendall Campus signifies a major leap forward for the regional biotech ecosystem, offering the hands-on training necessary to bridge science and advanced computation.

The Sunshine Genetics Act marks a turning point for Florida’s healthcare and biotech landscape, mandating broader screening and fostering an environment for diagnostic innovation.

This landmark merger marks a pivotal moment for Florida's entrepreneurial landscape, consolidating two of the state's most prominent angel groups. The newly formed entity is poised to streamline investment processes, expand mentor networks, and ultimately accelerate the growth of innovative companies across key industries, fostering a more dynamic and interconnected funding environment statewide. For life science and biotech founders, this represents a substantial opportunity for increased early-stage funding.

This detailed analysis explores the clinical trial NCT04092283, focusing on its innovative approach to enhance treatment outcomes for advanced non-small cell lung cancer, and its broader implications for pharmaceutical development and regional biotech ecosystems like South Florida.

Exploring the profound connection between environmental health and economic innovation, this article delves into how robust natural infrastructure, exemplified by the Everglades restoration, is not just a conservation success but a strategic asset underpinning the stability and growth of South Florida’s life science and biotech future.

This comprehensive article explores how the collaboration between FAU and Palm Beach County will enhance talent development, foster innovation, and contribute to the long-term economic vitality of the region, specifically focusing on its impact on the life science and biotech ecosystems and the opportunities it presents for professionals, businesses, and investors.